In Reply: Safety and Efficacy of the Off-Label Use of Pipeline Embolization Device Based on the 2018 Food and Drug Administration-Approved Indications for Intracranial Aneurysms: A Single-Center Retrospective Cohort Study.
Alejandro Enriquez-MarulandaAnirudh PenumakaChristopher S OgilvyAjith J ThomasJustin M MoorePublished in: Neurosurgery (2022)